Skip to main content

Dr. Marcus A. Urey, MD

Heart Failure & Transplant Cardiology (Advanced Heart Failure and Transplant Cardiology Physician)

200 W Arbor Dr
San Diego, CA 92103

Who else practices at this address →

San Diego County includes primary care (1% of residents) and mental health (1% of residents) shortage areas. About shortage areas

Call (858) 657-8530

  • Medicare participating

At a glance

Years since graduation
16
In the NPI registry since
2010
Medicare patients seen, 2024
351

Licensed in California since 2017, according to the Medical Board of California. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.

The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is

Education and training

  • 2010Medical school: University of California, Geffen School of Medicine
  • 2010Registered with an NPI (national billing number; not a license date)

Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).

Specialties and state licenses

  • Advanced Heart Failure and Transplant Cardiology Physician primary
    CA license A148944 (first issued 2017; current)
  • Cardiovascular Disease Physician
    CA license A148944 (first issued 2017; current)

As reported to the NPI registry. To confirm a license is current, check the state medical board.

Map: Heart Failure & Transplant Cardiology per capita by county →

Where they work

Hospitals

Medical groups

Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.

Medicare patients and services

Medicare patients, 2024
351
Services billed
1,233
Patients’ average age
71
Most frequent Medicare services, 2023
ServiceTimesPatients
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes21772
Established patient office or other outpatient visit, 30-39 minutes204151
Established patient office or other outpatient visit, 40-54 minutes11999
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes8334
Critical care, first 30-74 minutes6212
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes4946
New patient office or other outpatient visit, 60-74 minutes4848
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only4746
Hospital discharge day management, 30 minutes or less3937
Evaluation of lower heart chamber assist device2911

Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.

Medicare prescriptions

Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.

Payments from drug and device companies

In 2025, 7 companies reported 53 payments worth $76,025 in total to this clinician.

By company
Bridgebio Pharma, Inc.$44,005
AstraZeneca Pharmaceuticals LP$20,729
Alnylam Pharmaceuticals Inc.$9,983
Abiomed$840
Abbott Laboratories$400
Edwards Lifesciences Corporation$49.27
Scpharmaceuticals Inc.$19.07
By type
Compensation for services other than consulting (speaking, faculty)$49,630
Consulting Fee$19,262
Travel and Lodging$5,818
Food and Beverage$1,315

What the payments were for

Largest payments other than meals
DateCompanyWhat it was forAmount
May 27, 2025Bridgebio Pharma, Inc.
May 27, 2025
Consulting Fee
Attruby · Cardiomyopathy
$8,845
Apr 9, 2025AstraZeneca Pharmaceuticals LP
Apr 9, 2025
Compensation for services other than consulting (speaking, faculty)
WAINUA · Cardiovascular and Metabolism
Company’s descriptionSpeaker Fee
$4,300
Oct 16, 2025AstraZeneca Pharmaceuticals LP
Oct 16, 2025
Compensation for services other than consulting (speaking, faculty)
WAINUA · Cardiovascular and Metabolism
Company’s descriptionSpeaker Fee
$4,300
Nov 25, 2025Bridgebio Pharma, Inc.
Nov 25, 2025
Compensation for services other than consulting (speaking, faculty)
Attruby · Cardiomyopathy
$4,190
Oct 8, 2025Bridgebio Pharma, Inc.
Oct 8, 2025
Compensation for services other than consulting (speaking, faculty)
Attruby · Cardiomyopathy
$4,190
Apr 2, 2025AstraZeneca Pharmaceuticals LP
Apr 2, 2025
Consulting Fee
WAINUA · Cardiovascular and Metabolism
$3,759
Jun 2, 2025Alnylam Pharmaceuticals Inc.
Jun 2, 2025
Compensation for services other than consulting (speaking, faculty)
AMVUTTRA · Genetic Disease
$3,750
Feb 18, 2025Alnylam Pharmaceuticals Inc.
Feb 18, 2025
Compensation for services other than consulting (speaking, faculty)
AMVUTTRA · Genetic Disease
$2,820
Dec 5, 2025Bridgebio Pharma, Inc.
Dec 5, 2025
Compensation for services other than consulting (speaking, faculty)
Attruby · Cardiomyopathy
$2,793
Nov 25, 2025Bridgebio Pharma, Inc.
Nov 25, 2025
Compensation for services other than consulting (speaking, faculty)
Attruby · Cardiomyopathy
$2,793
All 36 payments other than meals, newest first
All payments other than meals
DateCompanyWhat it was forAmount
Dec 5, 2025Bridgebio Pharma, Inc.
Dec 5, 2025
Compensation for services other than consulting (speaking, faculty)
Attruby · Cardiomyopathy
$2,793
Nov 25, 2025Bridgebio Pharma, Inc.
Nov 25, 2025
Compensation for services other than consulting (speaking, faculty)
Attruby · Cardiomyopathy
$4,190
Nov 25, 2025Bridgebio Pharma, Inc.
Nov 25, 2025
Compensation for services other than consulting (speaking, faculty)
Attruby · Cardiomyopathy
$2,793
Nov 20, 2025Bridgebio Pharma, Inc.
Nov 20, 2025
Travel and Lodging
Attruby · Cardiomyopathy · travel to Las Vegas, NV
$162
Nov 20, 2025Bridgebio Pharma, Inc.
Nov 20, 2025
Travel and Lodging
Attruby · Cardiomyopathy · travel to Las Vegas, NV
$76.00
Nov 11, 2025Bridgebio Pharma, Inc.
Nov 11, 2025
Travel and Lodging
Attruby · Cardiomyopathy · travel to Las Vegas, NV · in-kind
$357
Nov 11, 2025Bridgebio Pharma, Inc.
Nov 11, 2025
Travel and Lodging
Attruby · Cardiomyopathy · travel to Las Vegas, NV · in-kind
$172
Oct 16, 2025AstraZeneca Pharmaceuticals LP
Oct 16, 2025
Compensation for services other than consulting (speaking, faculty)
WAINUA · Cardiovascular and Metabolism
Company’s descriptionSpeaker Fee
$4,300
Oct 9, 2025AstraZeneca Pharmaceuticals LP
Oct 9, 2025
Travel and Lodging
WAINUA · Cardiovascular and Metabolism · travel to Kahuku, HI · in-kind
Company’s descriptionSpeaker Expenses
$274
Oct 8, 2025Bridgebio Pharma, Inc.
Oct 8, 2025
Compensation for services other than consulting (speaking, faculty)
Attruby · Cardiomyopathy
$4,190
Oct 8, 2025Bridgebio Pharma, Inc.
Oct 8, 2025
Compensation for services other than consulting (speaking, faculty)
Attruby · Cardiomyopathy
$2,793
Oct 1, 2025AstraZeneca Pharmaceuticals LP
Oct 1, 2025
Consulting Fee
WAINUA · Cardiovascular and Metabolism
$2,685
Sep 9, 2025Bridgebio Pharma, Inc.
Sep 9, 2025
Consulting Fee
Attruby · Cardiomyopathy
$1,862
Jul 11, 2025Bridgebio Pharma, Inc.
Jul 11, 2025
Compensation for services other than consulting (speaking, faculty)
Attruby · Cardiomyopathy
$2,793
Jul 11, 2025Bridgebio Pharma, Inc.
Jul 11, 2025
Compensation for services other than consulting (speaking, faculty)
Attruby · Cardiomyopathy
$1,397
Jun 16, 2025AstraZeneca Pharmaceuticals LP
Jun 16, 2025
Compensation for services other than consulting (speaking, faculty)
WAINUA · Cardiovascular and Metabolism
Company’s descriptionSpeaker Fee
$100
Jun 5, 2025Bridgebio Pharma, Inc.
Jun 5, 2025
Compensation for services other than consulting (speaking, faculty)
Attruby · Cardiomyopathy
$2,793
Jun 5, 2025Bridgebio Pharma, Inc.
Jun 5, 2025
Compensation for services other than consulting (speaking, faculty)
Attruby · Cardiomyopathy
$2,793
Jun 5, 2025Bridgebio Pharma, Inc.
Jun 5, 2025
Compensation for services other than consulting (speaking, faculty)
Attruby · Cardiomyopathy
$2,793
Jun 5, 2025Bridgebio Pharma, Inc.
Jun 5, 2025
Compensation for services other than consulting (speaking, faculty)
Attruby · Cardiomyopathy
$2,793
Jun 2, 2025Alnylam Pharmaceuticals Inc.
Jun 2, 2025
Compensation for services other than consulting (speaking, faculty)
AMVUTTRA · Genetic Disease
$3,750
Jun 2, 2025Alnylam Pharmaceuticals Inc.
Jun 2, 2025
Travel and Lodging
AMVUTTRA · Genetic Disease · travel to Los Angeles, CA
$260
Jun 2, 2025Alnylam Pharmaceuticals Inc.
Jun 2, 2025
Travel and Lodging
AMVUTTRA · Genetic Disease · travel to Los Angeles, CA
$164
May 27, 2025Bridgebio Pharma, Inc.
May 27, 2025
Consulting Fee
Attruby · Cardiomyopathy
$8,845
May 27, 2025Bridgebio Pharma, Inc.
May 27, 2025
Compensation for services other than consulting (speaking, faculty)
Attruby · Cardiomyopathy
$90.88
Apr 24, 2025Alnylam Pharmaceuticals Inc.
Apr 24, 2025
Travel and Lodging
travel to San Diego, CA
$1,934
Apr 24, 2025Alnylam Pharmaceuticals Inc.
Apr 24, 2025
Travel and Lodging
travel to San Diego, CA
$962
Apr 9, 2025AstraZeneca Pharmaceuticals LP
Apr 9, 2025
Compensation for services other than consulting (speaking, faculty)
WAINUA · Cardiovascular and Metabolism
Company’s descriptionSpeaker Fee
$4,300
Apr 2, 2025AstraZeneca Pharmaceuticals LP
Apr 2, 2025
Consulting Fee
WAINUA · Cardiovascular and Metabolism
$3,759
Mar 29, 2025AstraZeneca Pharmaceuticals LP
Mar 29, 2025
Travel and Lodging
WAINUA · Cardiovascular and Metabolism · travel to Chicago, IL · in-kind
Company’s descriptionSpeaker Expenses
$699
Mar 29, 2025AstraZeneca Pharmaceuticals LP
Mar 29, 2025
Travel and Lodging
WAINUA · Cardiovascular and Metabolism · travel to Chicago, IL · in-kind
Company’s descriptionSpeaker Expenses
$655
Mar 29, 2025AstraZeneca Pharmaceuticals LP
Mar 29, 2025
Travel and Lodging
WAINUA · Cardiovascular and Metabolism · travel to Chicago, IL · in-kind
Company’s descriptionSpeaker Expenses
$105
Feb 18, 2025Alnylam Pharmaceuticals Inc.
Feb 18, 2025
Compensation for services other than consulting (speaking, faculty)
AMVUTTRA · Genetic Disease
$2,820
Feb 2, 2025AstraZeneca Pharmaceuticals LP
Feb 2, 2025
Consulting Fee$1,611
Jan 22, 2025AstraZeneca Pharmaceuticals LP
Jan 22, 2025
Compensation for services other than consulting (speaking, faculty)
WAINUA · Cardiovascular and Metabolism
Company’s descriptionSpeaker Fee
$2,150
Jan 7, 2025Abiomed
Jan 7, 2025
Consulting Fee$500

Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.

From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.

Who received the most in California →

Industry-funded research

Named as a principal investigator on 5 industry-funded studies in 2025, from 3 companies. The companies reported $373,364 in research payments for these studies, mostly to the institutions running them.

From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.

Other Heart Failure & Transplant Cardiology clinicians in San Diego

Sources

NPI registry (CMS NPPES, November 2026; record last updated October 3, 2017), Medicare Care Compare, Medicare Physician & Other Practitioners (2024), Medicare Part D Prescribers (2024) and Open Payments (2025). Information is self-reported or billed data and may be out of date; call before visiting.

NPI 1972820058. Official NPI registry record (opens in a new tab). Clinicians can correct their information in NPPES; changes appear here after our next monthly update.